INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Profit & Loss

Change Company Name

Lupin Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 500257	ISIN Demat INE326A01037	Book Value 481.38	NSE Symbol LUPIN	Dividend Yield (%) 0.41	Market Cap (₹ Cr.) 89,899.94	P/E 28.74	EPS 68.52	Face Value 2

Particulars (₹ Cr)	Mar2024	Mar2023	Mar2022	Mar2021	Mar2020
Revenue From Operations	14,666.50	11,258.83	11,771.67	11,055.93	11,025.66
Sale of Products	13,953.11	10,779.78	10,691.46	10,873.67	10,629.06
Sale of Services	363.32	263.29	567.02	27.35	176.77
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	350.07	215.76	513.19	154.91	219.83
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	14,666.50	11,258.83	11,771.67	11,055.93	11,025.66
Other Income	115.51	210.02	216.99	129.09	475.19
Total Revenue	14,782.01	11,468.85	11,988.66	11,185.02	11,500.85
Changes in Inventories	-15.93	120.79	-242.38	-81.86	-28.72
Cost of Material Consumed	3,407.30	3,151.20	2,816.90	2,741.22	2,753.22
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	1,633.86	1,525.70	1,892.74	1,522.95	1,482.77
Employee Benefits	2,095.51	1,934.14	1,918.16	1,695.86	1,703.22
Total Other Expenses	4,095.48	3,563.10	5,177.11	3,133.70	3,207.56
Manufacturing / Operating Expenses	1,626.93	1,603.02	1,627.54	1,525.33	1,524.96
Administrative and Selling Expenses	2,268.24	1,797.13	1,573.22	1,355.01	1,557.70
Other Expenses	200.31	162.95	1,976.35	253.36	124.90
Finance Costs	56.35	98.44	73.47	40.62	52.59
Depreciation and Amortization	724.75	548.34	514.19	502.83	518.75
Total Expenses	11,997.32	10,941.71	12,150.19	9,555.32	9,689.39
Profit Before Exceptional Items and Tax	2,784.69	527.14	-161.53	1,629.70	1,811.46
Exceptional Items Before Tax	0.00	0.00	0.00	0.00	-759.21
Profit Before Extraordinary Items and Tax	2,784.69	527.14	-161.53	1,629.70	1,052.25
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	2,784.69	527.14	-161.53	1,629.70	1,052.25
Taxation	458.60	101.93	27.17	371.08	324.70
Current Tax	484.05	95.89	57.80	367.10	367.90
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-25.45	6.04	-30.63	8.23	-37.35
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	0.00	0.00	0.00	-4.25	-5.85
Profit After Tax	2,326.09	425.21	-188.70	1,258.62	727.55
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Shareholders	2,326.09	425.21	-188.70	1,258.62	727.55
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	2,326.09	425.21	-188.70	1,258.62	727.55
Earning Per Share - Basic	51.10	9.35	-4.16	27.77	16.07
Earning Per Share - Diluted	50.87	9.31	-4.16	27.65	15.99
Operation Profit before Depreciation	3,565.79	1,173.92	426.13	2,173.15	2,382.80
Operating Profit after Depreciation	2,841.04	625.58	-88.06	1,670.32	1,864.05
Dividend Per Share	8.00	4.00	4.00	6.50	6.00
Dividend Percentage	400.00	200.00	200.00	325.00	300.00
Equity Dividend	364.60	181.99	181.80	294.92	271.84
Weighted Average Shares - Basic	45.52	45.47	45.40	45.33	45.27
Weighted Average Shares - Diluted	45.72	45.69	45.52	45.52	45.51